PreHevbrio™ (hepatitis B vaccine [recombinant]) – New vaccine approval
December 1, 2021 - VBI Vaccines announced the FDA approval of PreHevbrio (hepatitis B vaccine [recombinant]), for prevention of infection caused by all known subtypes of hepatitis B virus (HBV).
Download PDF
